Melatonin synergizes with citalopram to induce antidepressant-like behavior and to promote hippocampal neurogenesis in adult mice

Journal of Pineal Research

Volumn 56, Issue 4, 2014, Pages 450-461

  Ramírez Rodríguez, Gerardo ^a   Vega Rivera, Nelly Maritza ^a   Oikawa Sala, Julián ^a   Gómez Sánchez, Ariadna ^a   Ortiz López, Leonardo ^a   Estrada Camarena, Erika ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

adult neurogenesis; antidepressants; citalopram; hippocampus; melatonin; neurogenesis

Indexed keywords

CITALOPRAM; CORTICOSTERONE; MELATONIN; ANTIDEPRESSANT AGENT; ANTIOXIDANT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DENTATE GYRUS; DEPRESSION; DRUG POTENTIATION; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILIZATION; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NONHUMAN; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CITALOPRAM; DEPRESSION; DRUG SYNERGISM; HIPPOCAMPUS; MALE; MELATONIN; MICE; MICE, INBRED BALB C; NEUROGENESIS;

EID: 84898958295     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12136     Document Type: Article

References (88)

1. Kempermann G,. The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for? Trends Neurosci 2008; 31: 163-169.
2. Sahay A, Hen R,. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007; 10: 1110-1115.
3. Sahay A, Drew MR, Hen R,. Dentate gyrus neurogenesis and depression. Prog Brain Res 2007; 163: 697-722.
4. Duman RS,. Depression: a case of neuronal life and death? Biol Psychiatry 2004; 56: 140-145.
5. Dranovsky A, Picchini AM, Moadel T, et al. Experience dictates stem cell fate in the adult hippocampus. Neuron 2011; 70: 908-923.
6. Kempermann G, Krebs J, Fabel K,. The contribution of failing adult hippocampal neurogenesis to psychiatric disorders. Curr Opin Psychiatry 2008; 21: 290-295.
7. Malberg JE, Eisch AJ, Nestler EJ, et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
8. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-809.
9. Duman RS, Nakagawa S, Malberg J,. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001; 25: 836-44.
10. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153-C158.
11. Cardinali DP, Srinivasan V, Brzezinski A, et al. Melatonin and its analogs in insomnia and depression. J Pineal Res 2012; 52: 365-375.
12. Crupi R, Mazzon E, Marino A, et al. Melatonin treatment mimics the antidepressant action in chronic corticosterone-treated mice. J Pineal Res 2010; 49: 123-129.
13. Ramirez-Rodriguez G, Klempin F, Babu H, et al. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology 2009; 34: 2180-2191.
14. Overstreet DH, Pucilowski O, Retton MC, et al. Effects of melatonin receptor ligands on swim test immobility. NeuroReport 1998; 9: 249-253.
15. Benitez-King G,. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006; 40: 1-9.
16. Reiter RJ,. Melatonin, active oxygen species and neurological damage. Drug News Perspect 1998; 11: 291-296.
17. Reiter RJ,. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359-384.
18. Kilic E, Kilic U, Bacigaluppi M, et al. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res 2008; 45: 142-148.
19. Manda K, Ueno M, Anzai K,. Cranial irradiation-induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment. J Pineal Res 2009; 46: 71-78.
20. Manda K, Ueno M, Anzai K,. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J Pineal Res 2008; 45: 430-438.
21. Dubocovich ML,. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med 2007; 8 (Suppl 3): 34-42.
22. Dubocovich ML, Markowska M,. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110.
23. Dominguez-Alonso A, Ramirez-Rodriguez G, Benitez-King G,. Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures. J Pineal Res 2012; 52: 427-436.
24. Liu J, Somera-Molina KC, Hudson RL, et al. Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus. J Pineal Res 2013; 54: 222-231.
25. Carvalho LA, Gorenstein C, Moreno R, et al. Effect of antidepressants on melatonin metabolite in depressed patients. J Psychopharmacol 2009; 23: 315-321.
26. Crasson M, Kjiri S, Colin A, et al. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology 2004; 29: 1-12.
27. Pacchierotti C, Iapichino S, Bossini L, et al. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 2001; 22: 18-32.
28. Darcourt G, Souetre E, Pringuey D, et al. [Disorders of circadian rhythms in depression]. Encephale 1992; 4: 473-478.
29. Banasr M, Soumier A, Hery M, et al. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 2006; 59: 1087-1096.
30. Eser D, Baghai TC, Moller HJ,. Evidence of agomelatine's antidepressant efficacy: the key points. Int Clin Psychopharmacol 2007; 22 (Suppl 2): S15-S19.
31. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-1917.
32. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007; 9: 449-459.
33. Fava M, Rush AJ,. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother Psychosom 2006; 75: 139-153.
34. Fava M, Targum SD, Nierenberg AA, et al. An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. J Psychiatr Res 2013; 46: 1553-1563.
35. Thase ME, Howland RH, Friedman ES,. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 1998; 59 (Suppl. 5): 5-12; discussion 13-5.
36. Ergun Y, Orhan FO, Karaaslan MF,. Combination therapy of imipramine and melatonin: additive antidepressant effect in mouse forced swimming test. Eur J Pharmacol 2008; 591: 159-163.
37. Mahmood I, Sahajwalla C,. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 1999; 36: 277-287.
38. van Harten J,. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993; 24: 203-220.
39. Baumann P,. Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI). Int Clin Psychopharmacol 1992; 6 (Suppl 5): 13-20.
40. Plenge P, Mellerup ET,. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes. Eur J Pharmacol 1985; 119: 1-8.
41. Jayatissa MN, Bisgaard C, Tingstrom A, et al. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006; 31: 2395-2404.
42. Jaako-Movits K, Zharkovsky T, Pedersen M, et al. Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram administration. Cell Mol Neurobiol 2006; 26: 1559-1570.
43. Wang JW, David DJ, Monckton JE, et al. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 2008; 28: 1374-1384.
44. Bessa JM, Ferreira D, Melo I, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764-773, 739.
45. Surget A, Saxe M, Leman S, et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008; 64: 293-301.
46. Eisch AJ, Cameron HA, Encinas JM, et al. Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci 2008; 28: 11785-11791.
47. Henn FA, Vollmayr B,. Neurogenesis and depression: etiology or epiphenomenon? Biol Psychiatry 2004; 56: 146-150.
48. Tallarida RJ,. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001; 298: 865-872.
49. Silva-Moreno A, Gonzalez-Espinosa C, Leon-Olea M, et al. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with mu-opioid receptor internalization. Eur J Pharmacol 2012; 674: 239-247.
50. Montiel-Ruiz RM, Gonzalez-Trujano ME, Deciga-Campos M,. Synergistic interactions between the antinociceptive effect of Rhodiola rosea extract and B vitamins in the mouse formalin test. Phytomedicine 2013; 20: 1280-1287.
51. Tallarida RJ,. Statistical analysis of drug combinations for synergism. Pain 1992; 49: 93-97.
52. Tallarida RJ,. The interaction index: a measure of drug synergism. Pain 2002; 98: 163-168.
53. Porsolt RD, Bertin A, Jalfre M,. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
54. Porsolt RD, le Pichon M, Jalfre M,. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977; 266: 730-732.
55. Porsolt RD, Anton G, Blavet N, et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47: 379-391.
56. Ramirez-Rodriguez G, Ortiz-Lopez L, Dominguez-Alonso A, et al. Chronic treatment with melatonin stimulates dendrite maturation and complexity in adult hippocampal neurogenesis of mice. J Pineal Res 2011; 50: 29-37.
57. Ramirez-Rodriguez G, Vega-Rivera NM, Benitez-King G, et al. Melatonin supplementation delays the decline of adult hippocampal neurogenesis during normal aging of mice. Neurosci Lett 2012; 530: 53-58.
58. Kempermann G, Gast D, Kronenberg G, et al. Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 2003; 130: 391-399.
59. O'connor TM, O'halloran DJ, Shanahan F,. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM 2000; 93: 323-333.
60. Kempermann G, Jessberger S, Steiner B, et al. Milestones of neuronal development in the adult hippocampus. Trends Neurosci 2004; 27: 447-452.
61. Plumpe T, Ehninger D, Steiner B, et al. Variability of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the regulation of precursor cell proliferation. BMC Neurosci 2006; 7: 77-90.
62. Bearden CE, Thompson PM, Avedissian C, et al. Altered hippocampal morphology in unmedicated patients with major depressive illness. ASN Neuro 2009; 1: 265-273.
63. Ballmaier M, Narr KL, Toga AW, et al. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry 2008; 165: 229-237.
64. Shoval G, Nahshoni E, Gothelf D, et al. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study. Clin Neuropharmacol 2011; 34: 182-185.
65. Montgomery SA, Djarv L,. The antidepressant efficacy of citalopram. Int Clin Psychopharmacol 1996; 11 (Suppl. 1): 29-33.
66. Montgomery SA, Rasmussen JG,. Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 1992; 6 (Suppl. 5): 71-73.
67. Wennogle LP, Meyerson LR,. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes. Life Sci 1985; 36: 1541-1550.
68. Montgomery SA, Rasmussen JG, Lyby K, et al. Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. Int Clin Psychopharmacol 1992; 6 (Suppl. 5): 65-70.
69. Michel TM, Pulschen D, Thome J,. The role of oxidative stress in depressive disorders. Curr Pharm Des 2012; 18: 5890-5899.
70. Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2: 181-197.
71. Pittenger C, Duman RS,. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33: 88-109.
72. Zhao C, Teng EM, Summers RG Jr, et al. Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus. J Neurosci 2006; 26: 3-11.
73. Song H, Kempermann G, Overstreet Wadiche L, et al. New neurons in the adult mammalian brain: synaptogenesis and functional integration. J Neurosci 2005; 25: 10366-10368.
74. Ramirez-Rodriguez G, Ortiz-Lopez L, Benitez-King G,. Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C. J Pineal Res 2007; 42: 180-190.
75. Benitez-King G, Hernandez ME, Tovar R, et al. Melatonin activates PKC-alpha but not PKC-epsilon in N1E-115 cells. Neurochem Int 2001; 39: 95-102.
76. Bellon A, Ortiz-Lopez L, Ramirez-Rodriguez G, et al. Melatonin induces neuritogenesis at early stages in N1E-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase. J Pineal Res 2007; 42: 214-221.
77. Sapolsky RM,. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-935.
78. Imbesi M, Uz T, Manev H,. Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons. J Neural Transm 2008; 115: 1495-1499.
79. Sairanen M, Lucas G, Ernfors P, et al. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 2005; 25: 1089-1094.
80. Saarelainen T, Hendolin P, Lucas G, et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2003; 23: 349-357.
81. Taliaz D, Stall N, Dar DE, et al. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 2009; 15: 80-92.
82. Millan MJ, Brocco M, Gobert A, et al. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology 2005; 177: 448-458.
83. Stahl SM, Fava M, Trivedi MH, et al. Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial. J Clin Psychiatry 2010; 71: 616-626.
84. Kennedy SH, Rizvi SJ,. Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs 2010; 24: 479-499.
85. Kasper S, Hamon M,. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action. World J Biol Psychiatry 2009; 10: 117-126.
86. Goodwin GM,. Clinical studies on the efficacy of agomelatine on depressive symptoms. CNS Drugs 2009; 23 (Suppl. 2): 35-39.
87. Bourin M, Prica C,. Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression. Curr Pharm Des 2009; 15: 1675-1682.
88. Goodwin GM, Emsley R, Rembry S, et al. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2009; 70: 1128-1137.